BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32224200)

  • 1. Evaluation of polymyxin B in combination with 13 other antibiotics against carbapenemase-producing Klebsiella pneumoniae in time-lapse microscopy and time-kill experiments.
    Wistrand-Yuen P; Olsson A; Skarp KP; Friberg LE; Nielsen EI; Lagerbäck P; Tängdén T
    Clin Microbiol Infect; 2020 Sep; 26(9):1214-1221. PubMed ID: 32224200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of polymyxin B combinations against genetically well-characterised Klebsiella pneumoniae producing NDM-1 and OXA-48-like carbapenemases.
    Olsson A; Allander L; Shams A; Al-Farsi H; Lagerbäck P; Tängdén T
    Int J Antimicrob Agents; 2023 Nov; 62(5):106967. PubMed ID: 37716575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Antibiotic Combinations against Multidrug-Resistant Pseudomonas aeruginosa in Automated Time-Lapse Microscopy and Static Time-Kill Experiments.
    Olsson A; Wistrand-Yuen P; Nielsen EI; Friberg LE; Sandegren L; Lagerbäck P; Tängdén T
    Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32179531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of Polymyxin B in Combination with Aztreonam, Minocycline, Meropenem, and Rifampin against Escherichia coli Producing NDM and OXA-48-Group Carbapenemases.
    Olsson A; Hong M; Al-Farsi H; Giske CG; Lagerbäck P; Tängdén T
    Antimicrob Agents Chemother; 2021 Nov; 65(12):e0106521. PubMed ID: 34516251
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Huang D; Yu B; Diep JK; Sharma R; Dudley M; Monteiro J; Kaye KS; Pogue JM; Abboud CS; Rao GG
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28438930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing Klebsiella pneumoniae by in vitro time-kill experiments.
    Tängdén T; Hickman RA; Forsberg P; Lagerbäck P; Giske CG; Cars O
    Antimicrob Agents Chemother; 2014; 58(3):1757-62. PubMed ID: 24395223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing
    Zhang W; Guo Y; Li J; Zhang Y; Yang Y; Dong D; Zhu D; He P; Hu F
    Antimicrob Resist Infect Control; 2018; 7():142. PubMed ID: 30479755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergy of polymyxin B and minocycline against KPC-3- and OXA-48-producing Klebsiella pneumoniae in dynamic time-kill experiments: agreement with in silico predictions.
    Olsson A; Malmberg C; Zhao C; Friberg LE; Nielsen EI; Lagerbäck P; Tängdén T
    J Antimicrob Chemother; 2024 Feb; 79(2):391-402. PubMed ID: 38158772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymyxin B and fosfomycin thwart KPC-producing Klebsiella pneumoniae in the hollow-fibre infection model.
    Bulman ZP; Zhao M; Satlin MJ; Chen L; Kreiswirth BN; Walsh TJ; Nation RL; Li J; Tsuji BT
    Int J Antimicrob Agents; 2018 Jul; 52(1):114-118. PubMed ID: 29486233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymyxin Triple Combinations against Polymyxin-Resistant, Multidrug-Resistant, KPC-Producing Klebsiella pneumoniae.
    Aye SM; Galani I; Yu H; Wang J; Chen K; Wickremasinghe H; Karaiskos I; Bergen PJ; Zhao J; Velkov T; Giamarellou H; Lin YW; Tsuji BT; Li J
    Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32393492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymyxin B in Combination with Rifampin and Meropenem against Polymyxin B-Resistant KPC-Producing Klebsiella pneumoniae.
    Diep JK; Jacobs DM; Sharma R; Covelli J; Bowers DR; Russo TA; Rao GG
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Polymyxin Combination with the Antiretroviral Zidovudine Exerts Synergistic Killing against NDM-Producing Multidrug-Resistant Klebsiella pneumoniae.
    Lin YW; Abdul Rahim N; Zhao J; Han ML; Yu HH; Wickremasinghe H; Chen K; Wang J; Paterson DL; Zhu Y; Rao GG; Zhou QT; Forrest A; Velkov T; Li J
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic killing of NDM-producing MDR Klebsiella pneumoniae by two 'old' antibiotics-polymyxin B and chloramphenicol.
    Abdul Rahim N; Cheah SE; Johnson MD; Yu H; Sidjabat HE; Boyce J; Butler MS; Cooper MA; Fu J; Paterson DL; Nation RL; Bergen PJ; Velkov T; Li J
    J Antimicrob Chemother; 2015 Sep; 70(9):2589-97. PubMed ID: 26023209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Activity and Emergence of Resistance of Polymyxin B and ZTI-01 (Fosfomycin for Injection) against KPC-Producing Klebsiella pneumoniae.
    Diep JK; Sharma R; Ellis-Grosse EJ; Abboud CS; Rao GG
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of in vitro efficacy of meropenem/polymyxin B and meropenem/fosfomycin combinations against carbapenem resistant Klebsiella pneumoniae strains.
    Adaleti R; Nakipoğlu Y; Çalık Ş; Arıcı N; Kansak N; Şenbayrak S; Aksaray S
    Acta Microbiol Immunol Hung; 2023 Jun; 70(2):155-160. PubMed ID: 37133999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains.
    Rodríguez-Avial I; Pena I; Picazo JJ; Rodríguez-Avial C; Culebras E
    Int J Antimicrob Agents; 2015 Dec; 46(6):616-21. PubMed ID: 26391381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic and immunomodulatory effects of polymyxin B in combination with fosfomycin against KPC-2-producing Klebsiella pneumoniae.
    Sharma R; Garcia E; Diep JK; Lee VH; Minhaj F; Jermain B; Ellis-Grosse EJ; Abboud CS; Rao GG
    Int J Antimicrob Agents; 2022 Apr; 59(4):106566. PubMed ID: 35288260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents.
    Bratu S; Tolaney P; Karumudi U; Quale J; Mooty M; Nichani S; Landman D
    J Antimicrob Chemother; 2005 Jul; 56(1):128-32. PubMed ID: 15917285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of minocycline combined with aminoglycosides against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.
    Wentao N; Guobao L; Jin Z; Junchang C; Rui W; Zhancheng G; Youning L
    J Antibiot (Tokyo); 2018 May; 71(5):506-513. PubMed ID: 29416121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple combination antibiotic therapy for carbapenemase-producing Klebsiella pneumoniae: a systematic review.
    Jacobs DM; Safir MC; Huang D; Minhaj F; Parker A; Rao GG
    Ann Clin Microbiol Antimicrob; 2017 Nov; 16(1):76. PubMed ID: 29178957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.